Search by Drug Name or NDC

    NDC 65162-0372-10 Oxybutynin Chloride 10 mg/1 Details

    Oxybutynin Chloride 10 mg/1

    Oxybutynin Chloride is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is OXYBUTYNIN CHLORIDE.

    Product Information

    NDC 65162-0372
    Product ID 65162-372_18ebf19f-1c32-41b3-86d8-f089d5d22b89
    Associated GPIs 54100045207530
    GCN Sequence Number 041047
    GCN Sequence Number Description oxybutynin chloride TAB ER 24 10 MG ORAL
    HIC3 R1A
    HIC3 Description URINARY TRACT ANTISPASMODIC/ANTIINCONTINENCE AGENT
    GCN 19389
    HICL Sequence Number 002048
    HICL Sequence Number Description OXYBUTYNIN CHLORIDE
    Brand/Generic Generic
    Proprietary Name Oxybutynin Chloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Oxybutynin Chloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name OXYBUTYNIN CHLORIDE
    Labeler Name Amneal Pharmaceuticals LLC
    Pharmaceutical Class Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204010
    Listing Certified Through 2024-12-31

    Package

    NDC 65162-0372-10 (65162037210)

    NDC Package Code 65162-372-10
    Billing NDC 65162037210
    Package 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (65162-372-10)
    Marketing Start Date 2015-11-02
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.12452
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description OXYBUTYNIN CL ER 10 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis